Medicines Australia Advisory Council
The Medicines Australia Advisory Council was established in 2017 to provide advice to the Board on trends and issues impacting the pharmaceutical industry in the medium to long term to support the Board’s role in shaping strategy.
The Advisory Council offers a strategic and diverse perspective of the environment with a view to positively shaping the future of the industry. This includes:
- Consideration of domestic and international factors that will impact on the industry and its members over the next 5-10 years such as demographic, political, social, economic, technological, scientific, regulatory and legislative.
- Identifying relevant, prioritised and strategic issues – risks, opportunities and trends – that may inform Australia’s industry, health and medicines policy and may impact Medicines Australia and its members.
- Identifying potential options that will enable Medicines Australia to positively shape the operating environment.
The Council is currently on hiatus whilst the Board collects and distils feedback regarding the optimal role and remit for the council. The Board will consider the most effective make-up, workplan and focus for the council in 2025 and beyond.